Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Yin 2021 Nat Commun

From Bioblast
Publications in the MiPMap
Yin Z, Burger N, Kula-Alwar D, Aksentijević D, Bridges HR, Prag HA, Grba DN, Viscomi C, James AM, Mottahedin A, Krieg T, Murphy MP, Hirst J (2021) Structural basis for a complex I mutation that blocks pathological ROS production. Nat Commun 12:707.

» PMID: 33514727 Open Access

Yin Zhan, Burger Nils, Kula-Alwar Durvaraka, Aksentijevic Dunja, Bridges Hannah R, Prag Hiran A, Grba Daniel N, Viscomi Carlo, James Andrew M, Mottahedin Amin, Krieg Thomas, Murphy Michael P, Hirst Judy (2021) Nat Commun

Abstract: Mitochondrial complex I is central to the pathological reactive oxygen species (ROS) production that underlies cardiac ischemia-reperfusion (IR) injury. ND6-P25L mice are homoplasmic for a disease-causing mtDNA point mutation encoding the P25L substitution in the ND6 subunit of complex I. The cryo-EM structure of ND6-P25L complex I revealed subtle structural changes that facilitate rapid conversion to the "deactive" state, usually formed only after prolonged inactivity. Despite its tendency to adopt the "deactive" state, the mutant complex is fully active for NADH oxidation, but cannot generate ROS by reverse electron transfer (RET). ND6-P25L mitochondria function normally, except for their lack of RET ROS production, and ND6-P25L mice are protected against cardiac IR injury in vivo. Thus, this single point mutation in complex I, which does not affect oxidative phosphorylation but renders the complex unable to catalyse RET, demonstrates the pathological role of ROS production by RET during IR injury.

Bioblast editor: Plangger M O2k-Network Lab: IT Padova Viscomi C, SE Gothenburg Hagberg H


Labels: MiParea: Respiration 





HRR: Oxygraph-2k 

2021-02